ECSP034460A - Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos - Google Patents

Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos

Info

Publication number
ECSP034460A
ECSP034460A EC2003004460A ECSP034460A ECSP034460A EC SP034460 A ECSP034460 A EC SP034460A EC 2003004460 A EC2003004460 A EC 2003004460A EC SP034460 A ECSP034460 A EC SP034460A EC SP034460 A ECSP034460 A EC SP034460A
Authority
EC
Ecuador
Prior art keywords
antibacterials
special
medications
preparation
compounds
Prior art date
Application number
EC2003004460A
Other languages
English (en)
Inventor
Jozsef Aszodi
Claude Fromentin
Maxime Lampilas
David Alan Rowlands
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8853181&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP034460(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of ECSP034460A publication Critical patent/ECSP034460A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

La invención se refiere a nuevos compuestos heterocíclicos de fórmula general (I), y sus sales con una base o un ácido: La invención se refiere, igualmente, a un procedimiento de preparación de estos compuestos, así como a su utiización como medicamentos, en especial como antibacterianos.
EC2003004460A 2000-08-01 2003-01-30 Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos ECSP034460A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0010121A FR2812635B1 (fr) 2000-08-01 2000-08-01 Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens

Publications (1)

Publication Number Publication Date
ECSP034460A true ECSP034460A (es) 2003-03-10

Family

ID=8853181

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004460A ECSP034460A (es) 2000-08-01 2003-01-30 Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos

Country Status (42)

Country Link
US (5) US7112592B2 (es)
EP (1) EP1307457B1 (es)
JP (2) JP4515704B2 (es)
KR (1) KR100632906B1 (es)
CN (1) CN1289500C (es)
AP (1) AP1614A (es)
AR (1) AR031716A1 (es)
AT (1) ATE263768T1 (es)
AU (2) AU2001279905B2 (es)
BG (1) BG66094B1 (es)
BR (1) BRPI0112986B8 (es)
CA (1) CA2417475C (es)
CR (1) CR6895A (es)
CZ (1) CZ294956B6 (es)
DE (1) DE60102702T2 (es)
DK (1) DK1307457T3 (es)
DZ (1) DZ3397A1 (es)
EA (1) EA004920B1 (es)
EC (1) ECSP034460A (es)
EE (1) EE05183B1 (es)
ES (1) ES2220793T3 (es)
FR (1) FR2812635B1 (es)
HK (1) HK1060356A1 (es)
HR (1) HRP20030034B1 (es)
HU (1) HU226889B1 (es)
IL (2) IL154187A0 (es)
MA (1) MA26938A1 (es)
ME (2) ME00060B (es)
MX (1) MXPA03000881A (es)
NO (1) NO324940B1 (es)
NZ (1) NZ523707A (es)
OA (1) OA12347A (es)
PL (2) PL234468B1 (es)
PT (1) PT1307457E (es)
RS (1) RS50214B (es)
SI (1) SI1307457T1 (es)
SK (1) SK287597B6 (es)
TR (1) TR200400859T4 (es)
TW (1) TWI292401B (es)
UA (1) UA73791C2 (es)
WO (1) WO2002010172A1 (es)
ZA (1) ZA200300676B (es)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
FR2848210B1 (fr) * 2002-12-06 2007-10-19 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
MX338505B (es) 2005-12-07 2016-04-20 Basilea Pharmaceutica Ag Combinaciones utiles de antibioticos de monobactama con inhibidores de beta-lactamasa.
EA017448B1 (ru) 2006-07-13 2012-12-28 Ачиллион Фармасьютикалз, Инк. 4-амино-4-оксобутаноиловые пептиды как ингибиторы вирусной репликации
US20090298878A1 (en) * 2006-07-14 2009-12-03 Akira Matsumura Oxime compounds and the use thereof
JP2010504967A (ja) * 2006-09-27 2010-02-18 メルク エンド カムパニー インコーポレーテッド 新規なβ−ラクタマーゼ阻害剤
WO2008051763A1 (en) * 2006-10-23 2008-05-02 Irm Llc Cathepsin proteases inhibitors
EP2119702A4 (en) 2007-01-31 2010-12-08 Dainippon Sumitomo Pharma Co amide derivative
FR2914923B1 (fr) * 2007-04-12 2013-06-14 Novexel Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens.
JP5323063B2 (ja) 2007-05-31 2013-10-23 塩野義製薬株式会社 オキシイミノ化合物およびその使用
FR2921060B1 (fr) * 2007-09-14 2012-06-15 Novexel Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
KR101800610B1 (ko) * 2008-01-18 2017-11-23 머크 샤프 앤드 돔 코포레이션 베타­락타마제 억제제
EP2346820B1 (en) * 2008-06-11 2013-02-13 Shionogi & Co., Ltd. Oxycarbamoyl compounds and the use thereof
EP3260551A1 (en) 2008-06-19 2017-12-27 Astra Zeneca Holding France Use of (1r,2s,5r) 1,6-diazabicyclo [3.2.1] octane-2-carboxamide, 7-oxo-6-(sulfooxy)-, monosodium salt as a diagnostic reagent for detecting serine beta-lactamases
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
WO2010126820A2 (en) * 2009-04-30 2010-11-04 Merck Sharp & Dohme Corp. Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
KR20120109292A (ko) 2009-06-24 2012-10-08 다이닛본 스미토모 세이야꾸 가부시끼가이샤 Ｎ-치환-시클릭 아미노 유도체
FR2951171A1 (fr) * 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
US8772490B2 (en) 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
SG191320A1 (en) * 2010-12-22 2013-07-31 Meiji Seika Pharma Co Ltd Optically-active diazabicyclooctane derivative and method for manufacturing same
SG195289A1 (en) * 2011-06-17 2013-12-30 Astrazeneca Ab Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
PT2748165T (pt) * 2011-08-27 2016-12-28 Wockhardt Ltd Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona e sua utilização no tratamento de infeções bacterianas
CA2845108C (en) * 2011-08-30 2015-06-16 Wockhardt Limited 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections
BR112014003476A2 (pt) * 2011-09-13 2017-03-01 Wockhardt Ltd compostos contendo nitrogênio e seu uso
US8969567B2 (en) 2011-09-13 2015-03-03 Wockhardt Ltd. Nitrogen containing compounds and their use
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
US8927724B2 (en) 2012-03-30 2015-01-06 Cubist Pharmaceuticals, Inc. Isoxazole beta-lactamase inhibitors
US8916709B2 (en) 2012-03-30 2014-12-23 Cubist Pharmaceuticals, Inc. 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
MX2014011827A (es) 2012-03-30 2015-02-20 Cubist Pharm Inc Inhibidores de 1,3,4 - oxadiazol y 1,3,4 - tiadiazol b-lactamasa.
US8969570B2 (en) 2012-03-30 2015-03-03 Cubist Pharmaceuticals, Inc. Beta-lactamase inhibitors
AR090539A1 (es) 2012-04-02 2014-11-19 Astrazeneca Ab COMPUESTOS INHIBIDORES DE b LACTAMASA
ES2758507T3 (es) 2012-05-30 2020-05-05 Meiji Seika Pharma Co Ltd Nuevo inhibidor de B-lactamasa y método para producir el mismo
BR112015003592B1 (pt) * 2012-08-25 2020-04-14 Wockhardt Ltd derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas
EP2915805A4 (en) 2012-11-01 2016-03-23 Kaneka Corp METHOD FOR PRODUCING AN OPTICALLY ACTIVE BICYCLIC UREA COMPOUND
UA111925C2 (uk) 2012-12-11 2016-06-24 Федора Фармасьютікалз Інк. БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
WO2014129459A1 (ja) 2013-02-19 2014-08-28 株式会社エーピーアイ コーポレーション Ｌ－リジン水酸化酵素およびそれを利用したヒドロキシ－ｌ－リジンの製造法およびヒドロキシ－ｌ－ピペコリン酸の製造法
MX2015011723A (es) * 2013-03-08 2016-06-06 Wockhardt Ltd Proceso para la preparacion de una sal de sodio de (2s, 5r) -2-carboxamido-7-oxo-6-sulfooxi-1,6-diaza-biciclo[3.2.1]-octano.
BR112015021332B1 (pt) * 2013-03-08 2020-06-30 Wockhardt Limited sal de sódio de ácido (2s, 5r)-6-benzilóxi-7-oxo-1,6-diaza-biciclo [3.2.1] octano-2-carboxílico e sua preparação
WO2014152996A1 (en) 2013-03-14 2014-09-25 Cubist Pharmaceuticals, Inc. Crystalline form of a beta-lactamase inhibitor
JP6427173B2 (ja) * 2013-06-10 2018-11-21 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． ｔｅｒｔ−ブチル ４−（（１Ｒ，２Ｓ，５Ｒ）−６−（ベンジルオキシ）−７−オキソ−１，６−ジアザビシクロ［３．２．１］オクタン−２−カルボキサミド）ピペリジン−１−カルボキシレートの調製
MY193210A (en) 2013-09-24 2022-09-26 Meiji Seika Pharma Co Ltd Process for producing diazabicyclooctane derivative
US9120796B2 (en) 2013-10-02 2015-09-01 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
JP6617029B2 (ja) 2013-10-08 2019-12-04 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 ジアザビシクロオクタン誘導体の結晶とその製造法
AU2014333436A1 (en) 2013-10-11 2016-05-05 Wockhardt Limited Nitrogen containing compounds and their use
EP3096754B1 (en) 2014-01-22 2018-08-29 Merck Sharp & Dohme Corp. Metallo-beta-lactamase inhibitors
EP3139918B1 (en) 2014-05-09 2019-12-25 Merck Sharp & Dohme Corp. Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors
DK3221313T3 (en) * 2014-11-17 2019-04-08 Entasis Therapeutics Ltd COMBINATION THERAPY FOR TREATING INFECTIONS WITH RESISTANT BACTERIA
ES2812848T3 (es) 2014-12-02 2021-03-18 Merck Sharp & Dohme Proceso para la preparación de 4-((2S,5R)-6-(benciloxi)-7-oxo-1,6-diazabiciclo[3.2.1]octano-2-carboxamido)piperidin-1-carboxilato de terc-butilo y análogos del mismo
SG11201704576SA (en) 2014-12-05 2017-07-28 Meiji Seika Pharma Co Ltd Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
US10667737B2 (en) 2015-03-23 2020-06-02 International Business Machines Corporation Monitoring a person for indications of a brain injury
MX2017014080A (es) * 2015-05-07 2018-07-06 Mutabilis Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
EP3091018A1 (en) * 2015-05-07 2016-11-09 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
WO2016206101A1 (en) 2015-06-26 2016-12-29 Merck Sharp & Dohme Corp. Metallo-beta-lactamase inhibitors
WO2017002083A1 (en) 2015-07-02 2017-01-05 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
WO2017002087A1 (en) 2015-07-02 2017-01-05 Wockhardtlimited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
WO2017002089A1 (en) 2015-07-02 2017-01-05 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
WO2017002086A1 (en) 2015-07-02 2017-01-05 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
WO2017025526A1 (en) * 2015-08-10 2017-02-16 Sandoz Ag Form c of avibactam sodium
WO2017037607A1 (en) 2015-09-01 2017-03-09 Wockhardt Limited (aminomethylidene)amino-substituted (2s,5r)-6-(sulfonyl)-7-oxo-1,6-diazabicyclo[3.2.1 ]octane-2-carboxamide derivatives with antibacterial activity
CN107531709B (zh) 2015-09-16 2020-10-23 吉林四环制药有限公司 β-内酰胺酶抑制剂及其用途
JP6947634B2 (ja) 2015-10-02 2021-10-13 株式会社エーピーアイ コーポレーション ヒドロキシ−ｌ−ピペコリン酸の製造方法
KR20180051559A (ko) 2015-10-02 2018-05-16 주식회사 레고켐 바이오사이언스 베타-락타마제의 억제용 조성물 및 억제 방법
US20180282331A1 (en) 2015-11-09 2018-10-04 Wockhardt Limited 7-Oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections (changed by PCT to: 7-OXO -6-(SULFOOXY)- 1,6-DIAZABICYCLO [3.2.1] OCTANE CONTAINING COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS
CN106749242B (zh) * 2015-11-23 2021-04-02 上海医药工业研究院 阿维巴坦中间体的制备方法
US10472345B2 (en) 2016-02-04 2019-11-12 Merck Sharp & Dohme Corp. Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents
CN105753867B (zh) * 2016-03-24 2018-03-27 齐鲁制药有限公司 一种改进的阿维巴坦钠中间体化合物的制备方法
EP3156400B1 (en) 2016-05-27 2019-05-15 Valoralia I Más D, SL Dihydrooxadiazine compounds for treating infections and cancer
CN106279163A (zh) * 2016-08-12 2017-01-04 上海龙翔生物医药开发有限公司 一种合成阿维巴坦及其中间体光学异构体的方法
EP3504207B1 (en) * 2016-08-26 2022-06-01 Sandoz AG Avibactam free acid
LT3512851T (lt) 2016-09-16 2022-10-25 Entasis Therapeutics Limited Beta-laktamazės inhibitorių junginiai
JOP20190061A1 (ar) 2016-09-28 2019-03-26 Novartis Ag مثبطات بيتا-لاكتاماز
EP3301094A1 (en) * 2016-09-30 2018-04-04 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
CN106699756B (zh) * 2016-12-30 2019-10-29 淄博鑫泉医药技术服务有限公司 β内酰胺酶抑制剂阿维巴坦的合成方法
US20200017496A1 (en) * 2017-02-06 2020-01-16 Mutabilis Novel heterocyclic compounds and their use in preventing or treating bacterial infections
US11046694B2 (en) 2017-05-08 2021-06-29 Entasis Therapeutics, Inc. Compounds and methods for treating bacterial infections
US10085999B1 (en) 2017-05-10 2018-10-02 Arixa Pharmaceuticals, Inc. Beta-lactamase inhibitors and uses thereof
WO2018234962A1 (en) 2017-06-20 2018-12-27 Wockhardt Limited PROCESS FOR O-SULFONATION OF 1,6-DIAZABICYCLO [3.2.1] OCTANE COMPOUNDS
WO2019018186A1 (en) 2017-07-17 2019-01-24 Merck Sharp & Dohme Corp. METALLO-BETA-LACTAMASE INHIBITORS AND METHODS OF USE
SG11202002300QA (en) 2017-10-02 2020-04-29 Arixa Pharmaceuticals Inc Aztreonam derivatives and uses thereof
CN109678856B (zh) * 2017-10-18 2020-09-25 新发药业有限公司 一种阿维巴坦中间体的制备方法
WO2019101722A1 (en) 2017-11-23 2019-05-31 F. Hoffmann-La Roche Ag Proline hydroxylases as well as uses, methods and products involving the same
CN109956941B (zh) * 2017-12-25 2020-08-04 新发药业有限公司 一种阿维巴坦的简便制备方法
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
JP7437847B2 (ja) 2018-10-01 2024-02-26 アリクサ ファーマシューティカルズ、インコーポレイテッド レレバクタムの誘導体およびその使用
CN111072660B (zh) * 2018-10-22 2021-05-18 新发药业有限公司 一种瑞来巴坦的简便制备方法
CA3133071A1 (en) 2019-03-12 2020-09-17 Arixa Pharmaceuticals, Inc. Crystalline form of an avibactam derivative
WO2020219258A1 (en) 2019-04-25 2020-10-29 Arixa Pharmaceuticals, Inc. Methods of synthesizing aztreonam derivatives
CN110078728B (zh) * 2019-05-23 2020-10-23 江西富祥药业股份有限公司 一种阿维巴坦中间体、制备方法及其应用
WO2021106864A1 (en) * 2019-11-25 2021-06-03 Eisai R&D Management Co., Ltd. Process for the preparation of producing pyrazolo[1,5-a] pyrimidine derivatives
US11814385B2 (en) 2021-06-25 2023-11-14 University Of South Florida Small molecule inhibitors targeting Clostridioides difficile sporulation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4939678B1 (es) * 1968-05-06 1974-10-28
US4024147A (en) * 1972-06-30 1977-05-17 John Wyeth & Brother Limited Heterocyclic compounds
US4049821A (en) * 1976-05-12 1977-09-20 A. H. Robins Company, Inc. Method of treating allergy
JPS63119471A (ja) * 1986-09-02 1988-05-24 ザ・ユニバーシテイ・オブ・メルボルン ２−オキソ−４−カルボキシ−ピリミジン
EP0260057A3 (en) * 1986-09-02 1989-02-01 The University Of Melbourne 2-oxo-4-carboxy-pyrimidines
DE69416869T2 (de) * 1993-12-29 1999-07-01 Pfizer Diazabicyclische neurokinin antagonisten
TW358097B (en) * 1996-05-24 1999-05-11 Hoffmann La Roche Beta-lactams and their process and pharmaceutical compositions
HUP0001741A3 (en) * 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
YU35699A (sh) * 1997-02-10 2002-06-19 Pfizer Products Inc. 2-amino-6-(2-supstituisan-4-fenoksi)-supstituisani piridini
US6060585A (en) * 1997-03-04 2000-05-09 Wisconsin Alumni Research Foundation β-polypeptide foldamers of well-defined secondary structure
KR100207096B1 (ko) * 1997-07-08 1999-07-15 이명환 시사프라이드의 제조 방법
US6384080B1 (en) * 1998-04-20 2002-05-07 Fujisawa Pharmaceutical Co., Ltd. Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase
GB9817029D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
FR2784682B1 (fr) * 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
JP2002533454A (ja) * 1998-12-23 2002-10-08 イーライ・リリー・アンド・カンパニー 芳香族アミド類
BR9916732A (pt) * 1999-01-02 2001-09-25 Aventis Pharma Gmbh Derivados de ácido malÈnico, processo para a sua preparação, seu uso e composições farmacêuticas contendo-os (inibição da atividade do fator xa)
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases

Also Published As

Publication number Publication date
OA12347A (fr) 2006-05-15
NO20030494D0 (no) 2003-01-31
US20110213147A1 (en) 2011-09-01
CR6895A (es) 2007-07-12
US7732610B2 (en) 2010-06-08
IL154187A0 (en) 2003-07-31
CA2417475C (en) 2010-04-20
NZ523707A (en) 2005-02-25
BRPI0112986B8 (pt) 2021-05-25
ES2220793T3 (es) 2004-12-16
DZ3397A1 (fr) 2002-02-07
IL154187A (en) 2009-02-11
RS50214B (sr) 2009-07-15
PL401469A1 (pl) 2013-02-04
BR0112986A (pt) 2003-07-08
HUP0302943A3 (en) 2007-08-28
MA26938A1 (fr) 2004-12-20
US20030199541A1 (en) 2003-10-23
EA200300211A1 (ru) 2003-06-26
CN1289500C (zh) 2006-12-13
EP1307457B1 (fr) 2004-04-07
CZ2003223A3 (cs) 2003-08-13
KR100632906B1 (ko) 2006-10-13
WO2002010172A1 (fr) 2002-02-07
US20110021772A1 (en) 2011-01-27
PL365162A1 (en) 2004-12-27
EA004920B1 (ru) 2004-10-28
CZ294956B6 (cs) 2005-04-13
SK287597B6 (sk) 2011-03-04
CN1468242A (zh) 2004-01-14
CA2417475A1 (fr) 2002-02-07
PL234468B1 (pl) 2020-02-28
HRP20030034B1 (en) 2011-03-31
KR20030019642A (ko) 2003-03-06
US7638529B2 (en) 2009-12-29
AP2003002726A0 (en) 2003-06-30
NO20030494L (no) 2003-03-28
ME00060B (me) 2010-06-10
US8178554B2 (en) 2012-05-15
JP4515704B2 (ja) 2010-08-04
FR2812635B1 (fr) 2002-10-11
UA73791C2 (uk) 2005-09-15
HRP20030034A2 (en) 2004-02-29
AR031716A1 (es) 2003-10-01
ZA200300676B (en) 2004-05-10
AP1614A (en) 2006-05-21
SK1052003A3 (en) 2003-11-04
AU2001279905B2 (en) 2005-12-08
DE60102702T2 (de) 2005-04-07
AU7990501A (en) 2002-02-13
DK1307457T3 (da) 2004-08-09
EE05183B1 (et) 2009-06-15
JP2004505088A (ja) 2004-02-19
HU226889B1 (en) 2010-01-28
MXPA03000881A (es) 2003-06-06
YU6303A (sh) 2006-03-03
EE200300046A (et) 2004-10-15
US20060189652A1 (en) 2006-08-24
FR2812635A1 (fr) 2002-02-08
US20060046995A1 (en) 2006-03-02
NO324940B1 (no) 2008-01-07
SI1307457T1 (en) 2004-08-31
EP1307457A1 (fr) 2003-05-07
BG66094B1 (bg) 2011-04-29
MEP17108A (en) 2010-06-10
HK1060356A1 (en) 2004-08-06
HUP0302943A2 (hu) 2003-12-29
PL216028B1 (pl) 2014-02-28
US7112592B2 (en) 2006-09-26
TR200400859T4 (tr) 2004-06-21
DE60102702D1 (de) 2004-05-13
ATE263768T1 (de) 2004-04-15
PT1307457E (pt) 2004-08-31
BR0112986B1 (pt) 2014-04-01
BG107497A (bg) 2003-09-30
JP2010138206A (ja) 2010-06-24
TWI292401B (en) 2008-01-11

Similar Documents

Publication Publication Date Title
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
NO20025719D0 (no) Nye triazolpyrimidinforbindelser
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
MY144659A (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
BR0211473A (pt) Novos compostos
SE0102438D0 (sv) New compounds
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
ES2168737T3 (es) Inhibidores de la oxido nitrico sintasa.
MEP10408A (en) Platinum derivative pharmaceutical formulations
EA200500017A1 (ru) Новые соединения
UY27571A1 (es) 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
BR0017030A (pt) Derivados de tiazolilamida
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
CY1105387T1 (el) Υποκατεστημενα παραγωγα 2-διαλκυλαμινοαλκυλοδιφαινθλιου
UY26841A1 (es) Sales estables de ácido o-acetilsalicílico con aminoácidos básicos
BR0314379A (pt) Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase
ECSP045497A (es) "difenilazetidinonas sustituidas con grupos acidos, metodo para su producción, medicamentos que comprenden dichos compuestos y su uso"
AR029795A1 (es) Derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico sustituidos, procedimientos para su preparacion, su uso para la preparacion de medicamentos y medicamentos que contienen estos compuestos
BR0108990A (pt) Processo para preparação de derivados de pirimidona com atividade antifungos
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
UY27612A1 (es) Sales estables del ácido o-acetilsalicílico con aminoácidos básicos l l
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
SE0101978D0 (sv) New compounds
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
ATE446952T1 (de) Herstellungsverfahren von 2-cyanopyridinen